Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of California, San Diego
OHSU Knight Cancer Institute
University of California, San Diego
National Cancer Institute, Egypt
Kidney Cancer Research Bureau
University Health Network, Toronto
University Health Network, Toronto
University of Pittsburgh
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Chicago
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sun Yat-sen University
NuCana plc
University of Wisconsin, Madison
University of California, San Diego
Dana-Farber Cancer Institute
Cedars-Sinai Medical Center
Affiliated Hospital of Nantong University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen University
UNICANCER
Affiliated Hospital of Nantong University
Cedars-Sinai Medical Center
The University of Hong Kong
University of California, San Francisco
Yale University
Centre hospitalier de l'Université de Montréal (CHUM)
Rutgers, The State University of New Jersey
National Cancer Institute, Naples
Eye & ENT Hospital of Fudan University
Columbia University
Maastricht University Medical Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Providence Health & Services
Sun Yat-sen University
H. Lee Moffitt Cancer Center and Research Institute
Institut Bergonié
Herlev Hospital
Centre Leon Berard
Sun Yat-sen University
Groupe Oncologie Radiotherapie Tete et Cou
University Health Network, Toronto
Institut Català d'Oncologia